HF
RARE icon

HRT Financial’s Ultragenyx Pharmaceutical RARE Stock Holding History

HRT Financial’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-613,229
Closed -$15.2M – 5143
2026
Q1 		$12.8M Buy
613,229
+111,550
+22% +$2.51M 0.03% 522
2025
Q4 		$11.5M Buy
+501,679
New +$16.5M 0.04% 404
2025
Q3 		– Sell
-79,824
Closed -$2.9M – 3517
2025
Q2 		$2.9M Buy
79,824
+45,389
+132% +$1.64M 0.01% 764
2025
Q1 		$1.25M Buy
34,435
+5,935
+21% +$247K 0.01% 1031
2024
Q4 		$1.2M Buy
28,500
+4,825
+20% +$239K 0.01% 981
2024
Q3 		$1.31M Buy
+23,675
New +$1.21M 0.01% 1087
2024
Q2 		– Sell
-7,869
Closed -$367K – 2938
2024
Q1 		$367K Sell
7,869
-10,430
-57% -$492K ﹤0.01% 1430
2023
Q4 		$875K Buy
+18,299
New +$709K 0.01% 1058
2023
Q3 		– Sell
-59,300
Closed -$2.73M – 2963
2023
Q2 		$2.73M Buy
59,300
+48,838
+467% +$2.27M 0.03% 480
2023
Q1 		$419K Sell
10,462
-20,022
-66% -$859K 0.01% 1505
2022
Q4 		$1.41M Buy
+30,484
New +$1.2M 0.02% 750
2021
Q3 		– Sell
-156,948
Closed -$15M – 3676
2021
Q2 		$15M Buy
+156,948
New +$16.4M 0.14% 133

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

HRT Financial's RARE Position: Q2 2026 in Review

HRT Financial sold out of Ultragenyx Pharmaceutical (RARE) in Q2 2026, closing a stake of 613,229 shares — an estimated $15.2M sold.

HRT Financial first reported a position in RARE in Q2 2021 and held it in 12 quarters. The position peaked at $15M in Q2 2021. 311 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • HRT Financial reported no remaining Ultragenyx Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 613,229 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $15.2M.
  • HRT Financial first reported a position in Ultragenyx Pharmaceutical in Q2 2021 and held it in 12 quarters.
  • HRT Financial's Ultragenyx Pharmaceutical position peaked at $15M in Q2 2021.
  • 311 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.